CONTACT
+91 80 2808 2808
info@biocon.com

Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France

  • Posted by: BIOCON

Bengaluru, Karnataka, India, September 01, 2016:

Kiran Mazumdar Shaw, Chairperson & Managing Director of Biocon has been appointed ‘Chevalier de l’Ordre National de la Legion d’Honneur’ (Knight of the National Order of the French Legion of Honour) for her outstanding contribution and dedication to the Biosciences and Research field globally. The award will be conferred on behalf of the President of the French Republic at a special ceremony later this year.

It is an absolute privilege for me to be appointed ‘Chevalier l’Ordre National de la Legion d’Honneur’ and I am deeply grateful to the French Government for this great honour. I owe this recognition to my wonderful team at Biocon who have joined me in my mission to harness the power of Biotechnology to provide affordable access to life saving biopharmaceuticals for Cancer and Diabetes” Kiran Mazumdar Shaw, Chairperson & Managing Director of Biocon.

Chevalier l’Ordre National de la Legion d’Honneur, created in 1802, by Napoleon Bonaparte, is the highest civilian award of the French Republic for outstanding contribution in diverse fields bestowed on citizens of the world. The award is conferred by the President of the French Republic. Other Indians to have received this honour in the past are: Yashwant Sinha, Narayana Murthy, Amitabh Bachchan, Aishwarya Rai, Nandita Das, Shah Rukh Khan, veteran musician Balamuralikrishna, Sivaji Ganesan amongst others.

Author: BIOCON
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>